Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma.

Coeffic, D; Benhammouda, A; Antoine, E C; Rixe, O; Paraiso, D; Auclerc, G; Renody, N; Mularoni, E; Soubrane, C; Weil, M; Mortier, N; Khayat, D

Coeffic, D; Benhammouda, A; Antoine, E C; Rixe, O; Paraiso, D; Auclerc, G; Renody, N; Mularoni, E; Soubrane, C; Weil, M; Mortier, N; Khayat, D.

Affiliation

Coeffic D; Medical Oncology Department, Salpêtrière Hospital, Paris, France.

Semin Oncol ; 24(1 Suppl 2): S2-38-S2-40, 1997 Feb.

Article in En | MEDLINE | ID: mdl-9045335

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Ovarian Neoplasms/drug therapy; Paclitaxel/administration & dosage; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Feasibility Studies; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms/pathology; Remission Induction

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Semin Oncol Year: 1997 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links